"ZEN-3694 does not work on its own. It works in combination with existing(and maybe future) cancer drugs. By using this combination, all of these companies have the ability to extend their current sales cycle by .5, 1, 2, 4 years. Any company that buys ZEL could look forward to sales as a result of patients on other companies drug being prescribed 3694 in addition to whatever drug they are currently taking."

Yes , thanks for that. 

 "Any company that buys ZEL could look forward to sales as a result of patients on other companies drug being prescribed 3694 in addition to whatever drug they are currently taking."

For sure , in the end all i was trying to say is a buyout sooner than later looks just as possible as one being done years down the road.